CIK 0001430306 · Non-accelerated filer<br>Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 261434750
- Phone
- 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- Open-market buys, last 90 days
- $60,455
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$60,455. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-10-31 | LEDERMAN SETH Chief Executive Officer | Purchase | +10,000 | 90,815 | ||
| 2016-10-31 | LEDERMAN SETH Chief Executive Officer | Purchase · Common Stock Purchase Warrant | +10,000 | 10,000 | ||
| 2016-10-31 | Rhodes John B Director | Purchase | +25,000 | 137,196 | ||
| 2016-10-31 | Rhodes John B Director | Purchase · Common Stock Purchase Warrant | +25,000 | 25,000 | ||
| 2016-10-31 | MARIO ERNEST Director | Purchase | +100,000 | 630,724 | ||
| 2016-10-31 | MARIO ERNEST Director | Purchase · Common Stock Purchase Warrant | +100,000 | 100,000 | ||
| 2016-09-13 | MARIO ERNEST Director | Purchase | +100,000 | $0.79 | $79K | 530,724 |
| 2016-06-22 | LEDERMAN SETH Chief Executive Officer | Purchase | +20,000 | $2.08 | $42K | 20,000 |
| 2016-06-21 | Saks Samuel R Director | Purchase | +12,500 | $2.00 | $25K | 51,050 |
| 2016-06-21 | SAENGER BRADLEY Chief Financial Officer | Purchase | +2,000 | $2.00 | $4K | 6,039 |
| 2016-06-21 | Saks Samuel R Director | Purchase | +25,000 | $2.00 | $50K | 63,550 |
| 2016-06-21 | MARIO ERNEST Director | Purchase | +50,000 | $2.00 | $100K | 430,724 |
| 2016-06-21 | LEDERMAN SETH Chief Executive Officer | Purchase | +25,000 | $2.00 | $50K | 31,000 |
| 2016-06-21 | Rhodes John B Director | Purchase | +25,000 | $2.00 | $50K | 112,196 |
| 2016-06-21 | DAUGHERTY BRUCE See remarks | Purchase | +100,000 | $2.00 | $200K | 100,000 |
| 2016-06-03 | SULLIVAN GREGORY M Chief Medical Officer | Purchase | +20,000 | $2.50 | $50K | 43,185 |
| 2016-05-27 | Rhodes John B Director | Grant or award · Restricted Stock Unit | +11,250 | 11,250 | ||
| 2016-05-27 | Saks Samuel R Director | Grant or award · Restricted Stock Unit | +7,500 | 7,500 | ||
| 2016-05-27 | DAVIDSON STUART Director | Grant or award · Restricted Stock Unit | +7,500 | 7,500 | ||
| 2016-05-27 | MATHER CHARLES E IV Director | Grant or award · Restricted Stock Unit | +7,500 | 7,500 |
Page 15 of 25 · 482 trades